Laparoscopic sleeve gastrectomy for morbid obesity Our initial experience


COD: 01_2010_017-20 Categorie: ,

Vittorio Lombardo, Roberto Baratta, Giorgio Giannone

Ann. Ital. Chir., 2010; 81: 17-20

La mia nuova descrizione qui!

Price of a print issue €25.00

AIM OF THE STUDY: The outcomes and initial results of laparoscopic sleeve gastrectomy (LSG) were evaluated at our
METHODS: A retrospective analysis of the initial 6 patients who underwent laparoscopic sleeve gastrectomy (LSG), between
November 2006 and May 2008, was performed. The aim of this study was to assess the safety and short-term efficacy
of LSG as a treatment option for weight reduction. Data collected included operative time, postoperative complications,
length of hospital stay and degree of weight reduction.
RESULTS: Our 6 morbidly obese patients, who underwent LSG had an average preoperative BMI 58.2 kg/m2. There
were 2 women and 4 men, with mean age 45 (range 41 to 55 years). Indication for LSG was related to BMI, high
perioperative risk, and body habitus for five patients. One patient underwent LSG as an alternative to laparoscopic
adjustable gastric banding (LAGB). Mean operative time was 2 hours (range 1.5-2.5). We had no conversion to open
procedure. There were neither postoperative complications nor mortality. Median hospital stay was 2 days. For our first
4 patients Average %EWL and BMI were 24 % and 44.5 kg/m2 at 6 months and % 31.2 and 41.2 kg/m2 at 1 year
respectively. No patients have subsequently undergone a second-stage procedure.
CONCLUSIONS: In our initial experience, LSG is a safe and effective treatment option for the high-risk and super superobese
patient. Follow-up will be necessary to evaluate long-term results when performed as single stage operation for morbid